Donna E. Shalala sold Bruker Corporation (NASDAQ: BRKR)
Donna E. Shalala (D-FL), a U.S. Representative, has disclosed 1 trade in Bruker Corporation (BRKR) since 2019, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Donna E. Shalala sold $1,001 - $15,000 of Bruker Corporation (NASDAQ: BRKR) on June 24, 2019. Since that trade, BRKR is up +29.98% against the S&P 500 up +174.44%, an outperformance of -144.46%.
Data updated
Donna E. Shalala's BRKR trades vs the price
BRKR is up +29.98% since Donna E. Shalala sold on June 24, 2019, versus +174.44% for the S&P 500.
Performance since this trade
All Donna E. Shalala BRKR trades
Donna E. Shalala & BRKR trading FAQ
Is it legal for Donna E. Shalala to trade Bruker Corporation (BRKR) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bruker Corporation (BRKR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Donna E. Shalala sell BRKR?
Donna E. Shalala disclosed a sale of $1,001 - $15,000 of Bruker Corporation (BRKR) on June 24, 2019, according to public STOCK Act filings.
How has BRKR performed since Donna E. Shalala's trade?
Since Donna E. Shalala sold BRKR on June 24, 2019, the stock is up +29.98%, versus +174.44% for the S&P 500 over the same period, an outperformance of -144.46%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BRKR trades?
Quantellect tracks every disclosed congressional trade in Bruker Corporation (BRKR) on the Bruker Corporation congressional trading page, which aggregates filings across all members of Congress.
Donna E. Shalala's BRKR tradesAll congressional filings for Bruker CorporationDonna E. Shalala's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.